FOXO4-DRI
Research / preclinicalPeptide senolytic — disrupts FOXO4-p53 interaction in senescent cells.
Mechanism
Peptide senolytic. Peptide senolytic — disrupts FOXO4-p53 interaction in senescent cells. For full mechanism, dosing protocol, and stacking guidance, ask the AI Advisor or open the compound in-app.
Peer-Reviewed Studies (2)
Targeted Apoptosis of Senescent Cells (FOXO4-DRI)
Original discovery: peptide selectively eliminated senescent cells.
PubMed PMID 28340339 →FOXO4 in Senescence Signaling
Reviewed FOXO4 mechanism and therapeutic targeting.
PubMed PMID 30773784 →